Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease

Substitutive therapy using fetal striatal grafts in animal models of Huntington disease (HD) have already demonstrated obvious beneficial effects on motor indices1. Using a new phenotypic model of HD recently designed in primates2,3, we demonstrate here complete and persistent recovery in a frontal-type cognitive task two to five months after intrastriatal allografting. The striatal allografts also reduce the occurence of dystonia, a major abnormal movement associated with HD. These results show the capacity of fetal neurons to provide a renewed substrate for both cognitive and motor systems in the lesioned adult brain. They also support the use of neural transplantation as a potential therapy for HD.

[1]  Peter S. Harper,et al.  Huntington's disease , 1991 .

[2]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  N. Butters,et al.  Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. , 1978, Archives of neurology.

[4]  R. Roth,et al.  Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.

[5]  J. Schneider.  Behavioral and Neuropathological Consequences of Chronic Exposure to Low Doses of the Dopaminergic Neurotoxin MPTP , 1992 .

[6]  L. Squire,et al.  Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants. , 1989, Behavioral neuroscience.

[7]  M. Beal,et al.  Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease , 1996, The Journal of Neuroscience.

[8]  T. Robbins,et al.  Striatal Graft‐Associated Recovery of a Lesion‐Induced Performance Deficit in the Rat Requires Learning to Use The Transplant , 1992, The European journal of neuroscience.

[9]  W. Cowan,et al.  A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) , 1984, The Journal of comparative neurology.

[10]  M. Beal,et al.  Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Bjo¨rklund,et al.  Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival , 1985, Brain Research.

[12]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  S. Folstein,et al.  Differential cognitive impairment in alzheimer's disease and huntington's disease , 1988, Annals of neurology.

[14]  Stephen B. Dunnett,et al.  Functional neural transplantation , 1994 .

[15]  D. Riche,et al.  Ontogeny of Human Striatal DARPP-32 Neurons in Fetuses and Following Xenografting to the Adult Rat Brain , 1996, Experimental Neurology.

[16]  D. Riche,et al.  A primate model of Huntington's disease: Behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon , 1990, Experimental Neurology.

[17]  M. Peschanski,et al.  Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.

[18]  B. Jenkins,et al.  Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease , 1995, Neuroscience.

[19]  A. Björklund,et al.  Graft-induced behavioral recovery in an animal model of Huntington disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Riche,et al.  Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Johnson.  Immunocytochemistry: 2nd edn , 1980 .

[22]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.